Share on StockTwits

Iradimed Corp (NASDAQ:IRMD) released its earnings data on Tuesday. The company reported $0.13 earnings per share (EPS) for the quarter, Analyst Ratings Net reports. The company had revenue of $4.70 million for the quarter, compared to the consensus estimate of $2.80 million.

Shares of Iradimed Corp (NASDAQ:IRMD) opened at 11.04 on Tuesday. Iradimed Corp has a one year low of $7.94 and a one year high of $13.60. The stock’s 50-day moving average is $9. and its 200-day moving average is $9.. The company has a market cap of $115.0 million and a price-to-earnings ratio of 54.88.

On the ratings front, analysts at Roth Capital initiated coverage on shares of Iradimed Corp in a research note on Monday. They set a “buy” rating and a $14.00 price target on the stock.

iRadimed Corporation is a provider of non-magnetic intravenous (NASDAQ:IRMD) infusion pump systems that are safe for use during magnetic resonance imaging (MRI) procedures.

Receive News & Ratings for Iradimed Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iradimed Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.